Skip to main content
Clinical and Translational Medicine
Fig. 2 | Clinical and Translational Medicine

Fig. 2

From: Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patients

Fig. 2

The algorithm of selection of non-vitamin K antagonist oral anticoagulant (NOAC). This arm is used when a patient prefer a medicine twice a day administration. A patient with poor kidney function (CCr < 15 ml/min) cannot apply this algorithm. If a patient shows dysphagia, a NOAC which can be pulverized is considered for prescription. CCr creatinine clearance, BID twice a day oral administration

Back to article page